Powell Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Powell Investment Advisors, LLC
- $210 Million
- Q4 2024
A detailed history of Powell Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Powell Investment Advisors, LLC holds 7,040 shares of GILD stock, worth $684,288. This represents 0.31% of its overall portfolio holdings.
Number of Shares
7,040
Previous 7,040
-0.0%
Holding current value
$684,288
Previous $590,000
10.17%
% of portfolio
0.31%
Previous 0.28%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
1,963Shares Held
995MCall Options Held
10.5MPut Options Held
9.86M-
Black Rock Inc. New York, NY121MShares$11.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.2 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.44 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$6.01 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.85 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $122B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...